世界の気管支鏡検査市場(~2027年):製品別(気管支鏡(フレキシブル、リジッド、EBUS)、画像システム(ビデオプロセッサ)、付属品(細胞診ブラシ))、用途別(気管支治療)、有用性別(再利用可能)、エンドユーザー別(病院、ACS/クリニック)

【英語タイトル】Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic) - Global Forecast to 2027

MarketsandMarketsが出版した調査資料(MD7495-22)・商品コード:MD7495-22
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年9月20日
・ページ数:278
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

MarketsandMarkets社の最新調査レポートによると、世界の気管支鏡検査市場規模は、2022年25億ドルから2027年37億ドルまで年平均7.9%成長すると推定されます。当書は、気管支鏡検査の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(気管支鏡、画像システム、付属品、その他)分析、用途別(気管支治療、気管支診断)分析、有用性別(再利用可能、使い捨て)分析、エンドユーザー別(病院、ACS/クリニック)分析、地域別(北米、ヨーロッパ、アジア太平洋、その他地域)分析、競争状況、企業情報、隣接・関連市場などについて総合的にまとめています。なお、当書に掲載されている企業情報には、Olympus Corporation (Japan)、KARL STORZ (Germany)、Ambu A/S (Denmark)、Boston Scientific Corporation (US)、FUJIFILM Holdings Corporation (Japan)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の気管支鏡検査市場規模:製品別
- 気管支鏡検査用気管支鏡の市場規模
- 気管支鏡検査用画像システムの市場規模
- 気管支鏡検査用付属品の市場規模
- その他気管支鏡検査機器の市場規模
・世界の気管支鏡検査市場規模:用途別
- 気管支治療用気管支鏡検査の市場規模
- 気管支診断用気管支鏡検査の市場規模
・世界の気管支鏡検査市場規模:有用性別
- 気管支鏡検査用再利用可能製品の市場規模
- 気管支鏡検査用使い捨て製品の市場規模
・世界の気管支鏡検査市場規模:エンドユーザー別
- 病院用気管支鏡検査の市場規模
- ACS/クリニック用気管支鏡検査の市場規模
・世界の気管支鏡検査市場規模:地域別
- 北米の気管支鏡検査市場規模
- ヨーロッパの気管支鏡検査市場規模
- アジア太平洋の気管支鏡検査市場規模
- その他地域の気管支鏡検査市場規模
・競争状況
・企業情報

“世界の気管支鏡検査市場は、2022年25億米ドルから2027年37億米ドルまで、年平均成長率7.9%で成長すると予測”
市場成長の主な原動力は、呼吸器疾患の有病率の上昇、低侵襲手術に対する需要の高まり、気管支鏡検査施設に対する病院投資の増加、気管支鏡の技術的進歩です。一方、訓練を受けた医師や呼吸器専門医の不足は、この市場の成長にとって大きな課題となっています。

“2021年の気管支鏡検査市場は、製品別では気管支鏡が最大シェアを獲得”
気管支鏡検査市場は、製品別に気管支鏡、イメージングシステム、付属品、その他の気管支鏡機器に区分されます。2021年の気管支鏡機器市場で最大のシェアを占めるのは気管支鏡セグメントでした。このセグメントの大きなシェアは、イメージングシステムやアクセサリと比較して気管支鏡のコストが高いこと、肺がんの有病率の増加、技術の進歩に起因する可能性があります。

“気管支鏡検査市場は、2021年に気管支治療が用途別で最大シェアを獲得”
用途に基づき、気管支鏡検査市場は気管支治療と気管支診断にセグメント化されます。2021年には、気管支治療セグメントが市場の最大シェアを占めています。このセグメントの大きなシェアは、対象疾患の有病率の上昇に起因しています。

“2021年に気管支鏡で最大シェアを占めたのは北米”
気管支鏡検査市場は、地域別に北米、欧州、アジア太平洋、その他の地域に区分されます。2021年、気管支鏡機器市場で最大のシェアを持つのは北米でした。北米市場の大きなシェアは、慢性呼吸器疾患の罹患率と有病率の増加、米国における有利な償還シナリオ、カナダにおける肺がんの罹患率の上昇、医療費の急速な増加、高度な技術への容易なアクセス、およびこの地域における市場プレイヤーの強力なプレゼンスに起因することができます。

供給側の一次インタビューの内訳
- 企業タイプ別 ティア1 (20%) 、ティア2 (45%) 、ティア3 (35%)
- 役職別 Cレベル幹部(30%)、取締役(20%)、その他(50)
- 地域別 北米 (33%)、欧州 (24%)、アジア太平洋 (27%)、その他の地域 (16%)

レポート掲載企業一覧
• オリンパス株式会社(日本)
• KARL STORZ (Germany)
• Ambu A/S (Denmark)
• Boston Scientific Corporation (US)
• Ethicon (US)
• 富士フイルムホールディングス株式会社(日本)
• Medtronic (Ireland)
• HOYA株式会社(日本)
• Richard Wolf GmbH (Germany)
• Cook Medical (US)
• Broncus Medical Inc. (China)
• CONMED (US)
• Roper Technologies (US)
• Teleflex Incorporated (US)
• Laborie Medical Technologies Corp. (Canada)
• EFER Endoscopy (France)
• EMOS Technology GmbH (Germany)
• VBM Medizintechnik GmbH (Germany)
• Hunan Vathin Medical Instrument Co. Ltd. (China)
• Machida Endoscope Co. Ltd. (China)

調査範囲
本レポートでは、気管支鏡検査市場を製品、用途、使用性、患者、地域別に調査しています。また、市場成長に影響を与える要因(促進要因、阻害要因、課題、機会など)を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。また、気管支鏡検査市場全体に対する成長動向、展望、貢献度に関してミクロ市場を調査しています。レポートでは、4つの主要地域に関して市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供します:
- 市場への浸透: 気管支鏡検査市場の上位20社が提供する気管支鏡装置に関する包括的な情報。気管支鏡検査市場の製品、用途、使い勝手、患者、地域を分析。
- 市場開発: 有利な新興市場に関する包括的情報。主要地域における気管支鏡検査市場を分析しています。
- 市場の多様化: 気管支鏡検査市場における新製品、未開拓の地域、最近の開発、投資に関する網羅的な情報。
- 競争力の評価: 気管支鏡検査市場における主要企業の市場シェアと戦略を詳細に評価

❖ レポートの目次 ❖

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.3 MARKET SCOPE 40
1.3.1 MARKET SEGMENTATION 40
1.3.2 GEOGRAPHIC SCOPE 41
1.3.3 YEARS CONSIDERED 41
1.4 CURRENCY 42
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 42
1.7 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 46
FIGURE 2 PRIMARY SOURCES 46
2.1.2.1 Key data from primary sources 47
2.1.2.2 Key industry insights 48
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 48
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION 49
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION 50
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BRONCHOSCOPY EQUIPMENT MARKET 50
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 8 TOP-DOWN APPROACH 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
2.4 MARKET SHARE ANALYSIS 54
2.5 STUDY ASSUMPTIONS 54
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 54
TABLE 1 RISK ANALYSIS 54
3 EXECUTIVE SUMMARY 55
FIGURE 10 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 55
FIGURE 11 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 56
FIGURE 12 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2022 VS. 2027 (USD MILLION) 56
FIGURE 13 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2022 VS. 2027 (USD MILLION) 57
FIGURE 14 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 57
FIGURE 15 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 58
4 PREMIUM INSIGHTS 59
4.1 BRONCHOSCOPY EQUIPMENT MARKET OVERVIEW 59
FIGURE 16 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 59
4.2 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT AND COUNTRY (2021) 60
FIGURE 17 BRONCHOSCOPES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 60
4.3 GEOGRAPHICAL SNAPSHOT OF BRONCHOSCOPY EQUIPMENT MARKET 61
FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 19 BRONCHOSCOPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.2.1 DRIVERS 63
5.2.1.1 Rising prevalence of respiratory diseases 63
5.2.1.2 Increasing cases of lung cancer 63
TABLE 2 LUNG CANCER INCIDENCE, BY COUNTRY, 2020 63
5.2.1.3 Growing demand for minimally invasive surgeries 64
5.2.1.4 Growing hospital investments in bronchoscopy facilities 64
5.2.1.5 Technological advancements 65
5.2.2 RESTRAINTS 65
5.2.2.1 High overhead cost of bronchoscopy procedures 65
TABLE 3 AGE, NUMBER OF REPAIRS, AVERAGE REPAIR COST PER BREAKAGE, RANGE OF REPAIR COST, AND TOTAL REPAIR COST BY SCOPE OVER A 3-YEAR PERIOD (MAY 2018–APRIL 2021) 66
5.2.2.2 Risks associated with bronchoscopy 66
5.2.3 OPPORTUNITIES 67
5.2.3.1 Growing healthcare market in emerging economies 67
FIGURE 20 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRICS COUNTRIES, 2012–2019 68
5.2.4 CHALLENGES 68
5.2.4.1 Dearth of trained physicians and pulmonologists 68
5.2.5 BURNING ISSUES 68
5.2.5.1 Product recalls 68
TABLE 4 LIST OF PRODUCT RECALLS 68
5.3 RANGES/SCENARIOS 69
FIGURE 21 REALISTIC SCENARIO 69
FIGURE 22 PESSIMISTIC SCENARIO 70
FIGURE 23 OPTIMISTIC SCENARIO 70
5.4 REGULATORY ANALYSIS 71
TABLE 5 LIST OF REGULATORY AUTHORITIES 71
5.4.1 NORTH AMERICA 71
5.4.1.1 US 71
TABLE 6 US: FDA MEDICAL DEVICE CLASSIFICATION 72
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
5.4.1.2 Canada 73
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
5.4.2 EUROPE 73
5.4.3 ASIA PACIFIC 73
5.4.3.1 Japan 73
TABLE 9 JAPAN: CLASSIFICATION OF MEDICAL DEVICES 74
5.4.3.2 China 74
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
5.4.3.3 India 76
5.5 PORTER’S FIVE FORCES ANALYSIS 77
5.5.1 THREAT OF NEW ENTRANTS 77
5.5.1.1 High capital requirement 77
5.5.1.2 High preference for products from well-established brands 77
5.5.2 THREAT OF SUBSTITUTES 77
5.5.2.1 Substitute therapies for bronchoscopy 77
5.5.3 BARGAINING POWER OF SUPPLIERS 78
5.5.3.1 Presence of several raw material suppliers 78
5.5.3.2 Supplier switching cost 78
5.5.4 BARGAINING POWER OF BUYERS 78
5.5.4.1 Few companies offer premium products at global level 78
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.5.5.1 Increasing demand for high-quality and innovative products 78
5.5.5.2 Lucrative growth potential in emerging markets 78
5.6 SUPPLY CHAIN ANALYSIS 79
FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 79
5.7 VALUE CHAIN ANALYSIS 80
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 80
5.8 ECOSYSTEM ANALYSIS 81
FIGURE 26 ECOSYSTEM ANALYSIS OF BRONCHOSCOPY EQUIPMENT MARKET 81
5.8.1 ROLE IN ECOSYSTEM 81
FIGURE 27 KEY PLAYERS IN BRONCHOSCOPY EQUIPMENT MARKET ECOSYSTEM 82
5.9 TECHNOLOGY ANALYSIS 82
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 83
TABLE 11 BRONCHOSCOPY EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 83
5.11 PATENT ANALYSIS 86
5.11.1 PATENT TRENDS FOR BRONCHOSCOPY EQUIPMENT 86
FIGURE 28 PATENT TRENDS FOR BRONCHOSCOPES, JANUARY 2011–AUGUST 2022 86
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BRONCHOSCOPES PATENTS, JANUARY 2011— AUGUST 2022 87
5.12 TRADE ANALYSIS 87
TABLE 12 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION) 87
TABLE 13 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION) 88
5.13 PRICING ANALYSIS 88
TABLE 14 AVERAGE SELLING PRICE OF BRONCHOSCOPES 88
TABLE 15 COST OF BRONCHOSCOPY EQUIPMENT 88
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 91
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 91
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 91
5.14.2 BUYING CRITERIA 91
FIGURE 31 KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT 91
TABLE 17 KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT 92
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92
5.15.1 REVENUE POCKETS FOR BRONCHOSCOPY EQUIPMENT MANUFACTURERS 92
FIGURE 32 REVENUE SHIFT FOR BRONCHOSCOPY EQUIPMENT 92
6 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT 93
6.1 INTRODUCTION 94
TABLE 18 BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
6.2 BRONCHOSCOPES 94
TABLE 19 FLEXIBLE VS. RIGID BRONCHOSCOPY 95
TABLE 20 INDICATIONS FOR FLEXIBLE AND RIGID BRONCHOSCOPY 95
TABLE 21 BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 22 BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 96
6.2.1 BY TYPE 96
6.2.1.1 Flexible bronchoscopes 96
6.2.1.1.1 Most widely adopted bronchoscopes 96
TABLE 23 ADVANTAGES AND DISADVANTAGES OF FLEXIBLE BRONCHOSCOPES 97
TABLE 24 FLEXIBLE BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 97
6.2.1.2 Rigid bronchoscopes 97
6.2.1.2.1 Complications associated with rigid bronchoscopy to limit adoption 97
TABLE 25 ADVANTAGES AND DISADVANTAGES OF RIGID BRONCHOSCOPES 98
TABLE 26 RIGID BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 98
6.2.1.3 EBUS bronchoscopes 98
6.2.1.3.1 EBUS bronchoscopes to register steady growth during forecast period 98
TABLE 27 EBUS BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 99
6.2.2 BY WORKING CHANNEL DIAMETER 99
TABLE 28 BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 99
6.2.2.1 2.8 mm 99
6.2.2.1.1 2.8 mm segment to account for largest market share 99
TABLE 29 2.8 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 100
6.2.2.2 2.2 mm 100
6.2.2.2.1 2.2 mm bronchoscopes mainly used in pediatric patients 100
TABLE 30 2.2 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 100
6.2.2.3 3.0 mm 101
6.2.2.3.1 Patient discomfort associated with 3.0 mm diameters limits market growth 101
TABLE 31 3.0 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 101
6.2.2.4 Other working channel diameters 101
TABLE 32 BRONCHOSCOPES MARKET FOR OTHER WORKING CHANNEL DIAMETERS, BY REGION, 2020–2027 (USD MILLION) 102
6.3 IMAGING SYSTEMS 102
TABLE 33 BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 34 BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.3.1 VIDEO PROCESSORS 103
6.3.1.1 Video processors to register highest growth during forecast period 103
TABLE 35 VIDEO PROCESSORS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.3.2 LIGHT SOURCES 104
6.3.2.1 Light sources essential components of bronchoscopy visualization systems 104
TABLE 36 LIGHT SOURCES MARKET, BY REGION, 2020–2027 (USD MILLION) 104
6.3.3 CAMERA HEADS 104
6.3.3.1 Technological advancements support market growth 104
6.3.3.2 Single-chip cameras 104
6.3.3.3 3-chip cameras 104
6.3.3.4 HD cameras 104
6.3.3.5 3D cameras 105
6.3.3.6 4K camera heads 105
TABLE 37 CAMERA HEADS MARKET, BY REGION, 2020–2027 (USD MILLION) 105
6.3.4 WIRELESS DISPLAYS AND MONITORS 105
6.3.4.1 Essential in diagnostic and therapeutic procedures 105
TABLE 38 WIRELESS DISPLAYS AND MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 106
6.3.5 OTHER COMPONENTS 106
TABLE 39 OTHER COMPONENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 106
6.4 ACCESSORIES 107
TABLE 40 BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 41 BRONCHOSCOPY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 107
6.4.1 CYTOLOGY BRUSHES 108
6.4.1.1 Used to collect cell samples from bronchus 108
TABLE 42 CYTOLOGY BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.4.2 TRANSBRONCHIAL ASPIRATION NEEDLES 108
6.4.2.1 Transbronchial aspiration needles projected to witness highest growth during forecast period 108
TABLE 43 TRANSBRONCHIAL ASPIRATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.4.3 BIOPSY FORCEPS 109
6.4.3.1 Biopsy forceps aid in diagnosing malignant and nonmalignant disorders 109
TABLE 44 BIOPSY FORCEPS MARKET, BY REGION, 2020–2027 (USD MILLION) 109
6.4.4 BIOPSY VALVES 109
6.4.4.1 Biopsy valves designed for one-time use 109
TABLE 45 BIOPSY VALVES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.4.5 CLEANING BRUSHES 110
6.4.5.1 Stringent regulations for cleaning bronchoscopes to drive market 110
TABLE 46 CLEANING BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.4.6 MOUTHPIECES 111
6.4.6.1 Growing number of bronchoscopy procedures performed to support adoption of mouthpieces 111
TABLE 47 MOUTHPIECES MARKET, BY REGION, 2020–2027 (USD MILLION) 111
6.4.7 OTHER ACCESSORIES 111
TABLE 48 OTHER ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 112
6.5 OTHER BRONCHOSCOPY EQUIPMENT 112
TABLE 49 OTHER BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 113
7 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION 114
7.1 INTRODUCTION 115
TABLE 50 DIAGNOSTIC AND THERAPEUTIC APPLICATIONS OF BRONCHOSCOPY 115
TABLE 51 BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
7.2 BRONCHIAL TREATMENT 116
7.2.1 LARGEST AND FASTEST-GROWING MARKET SEGMENT 116
TABLE 52 BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL TREATMENT, BY REGION, 2020–2027 (USD MILLION) 116
7.3 BRONCHIAL DIAGNOSIS 116
7.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE MARKET 116
TABLE 53 NUMBER OF DIAGNOSTIC BRONCHOSCOPY PROCEDURES WITH OR WITHOUT BIOPSY, BY COUNTRY, 2014–2018 117
TABLE 54 BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 117
8 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY 118
8.1 INTRODUCTION 119
TABLE 55 BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 119
8.2 REUSABLE EQUIPMENT 119
8.2.1 REUSABLE EQUIPMENT OFFERS HIGH IMAGE QUALITY 119
TABLE 56 REUSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 120
8.3 DISPOSABLE EQUIPMENT 120
8.3.1 DISPOSABLE EQUIPMENT SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 120
TABLE 57 DISPOSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 121
9 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT 122
9.1 INTRODUCTION 123
TABLE 58 BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 123
9.2 ADULT PATIENTS 123
9.2.1 HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES IN ADULT PATIENTS MAJOR FACTOR DRIVING MARKET GROWTH 123
TABLE 59 BRONCHOSCOPY EQUIPMENT MARKET FOR ADULT PATIENTS, BY REGION, 2020–2027 (USD MILLION) 124
9.3 PEDIATRIC PATIENTS 124
9.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING COUNTRIES TO SUPPORT MARKET GROWTH 124
TABLE 60 RIGID BRONCHOSCOPE SIZES FOR CHILDREN 124
TABLE 61 BRONCHOSCOPY EQUIPMENT MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020–2027 (USD MILLION) 125
10 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER 126
10.1 INTRODUCTION 127
TABLE 62 MEDICARE NATIONAL AVERAGE COVERAGE FOR BRONCHOSCOPY PROCEDURES AT HOSPITALS, AMBULATORY SURGERY CENTERS, AND IN-OFFICE FACILITIES, 2019 127
TABLE 63 BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10.2 HOSPITALS 128
10.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR BRONCHOSCOPY EQUIPMENT 128
TABLE 64 BRONCHOSCOPY EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 129
10.3 AMBULATORY SURGERY CENTERS/CLINICS 130
10.3.1 COST-EFFECTIVENESS OF ASCS TO DRIVE MARKET 130
TABLE 65 US: NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, 2013–2017 130
TABLE 66 US: AMBULATORY SURGERY CENTER PROCEDURES, 2015–2021 (MILLION) 130
TABLE 67 US: AMBULATORY SURGERY CENTERS, BY STATE, 2019 131
TABLE 68 BRONCHOSCOPY EQUIPMENT MARKET FOR AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2020–2027 (USD MILLION) 131
11 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION 132
11.1 INTRODUCTION 133
TABLE 69 LUNG CANCER CASES, BY REGION, 2020 133
TABLE 70 DEATHS DUE TO LUNG CANCER, BY REGION, 2020 133
TABLE 71 FIVE-YEAR PREVALENCE OF LUNG CANCER, BY REGION, 2020 134
TABLE 72 BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 134
11.2 NORTH AMERICA 135
FIGURE 33 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT 135
TABLE 73 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 74 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 75 NORTH AMERICA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 76 NORTH AMERICA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 137
TABLE 77 NORTH AMERICA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 78 NORTH AMERICA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 79 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138
TABLE 80 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 138
TABLE 81 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 139
TABLE 82 NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 139
11.2.1 US 139
11.2.1.1 Largest market for bronchoscopy equipment due to high healthcare spending 139
TABLE 83 US: LUNG CANCER INCIDENCE, 2020 VS. 2040 139
TABLE 84 US: KEY MACROINDICATORS 140
TABLE 85 MEDICARE COVERAGE FOR BRONCHOSCOPY PROCEDURES 140
TABLE 86 US: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 87 US: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 88 US: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 142
TABLE 89 US: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 90 US: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 91 US: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 92 US: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 143
TABLE 93 US: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 143
TABLE 94 US: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 143
11.2.2 CANADA 144
11.2.2.1 Long waiting period for bronchoscopy procedures to restrain market growth 144
TABLE 95 CANADA: LUNG CANCER INCIDENCE, 2018 VS. 2025 144
TABLE 96 CANADA: KEY MACROINDICATORS 145
TABLE 97 CANADA: MEDIAN PATIENT WAITING PERIODS FOR TREATMENT AFTER APPOINTMENT WITH SPECIALISTS FOR BRONCHOSCOPY (2018) 145
TABLE 98 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 99 CANADA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 100 CANADA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 146
TABLE 101 CANADA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 102 CANADA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 103 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 104 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 147
TABLE 105 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 148
TABLE 106 CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 148
11.3 EUROPE 148
TABLE 107 EUROPE: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE OF LUNG CANCER, BY COUNTRY, 2020 148
TABLE 108 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 109 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 110 EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 111 EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 151
TABLE 112 EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 113 EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 114 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 115 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 152
TABLE 116 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 153
TABLE 117 EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 153
11.3.1 GERMANY 153
11.3.1.1 Germany dominates European bronchoscopy equipment market 153
TABLE 118 GERMANY: LUNG CANCER INCIDENCE, 2018 VS. 2025 153
TABLE 119 GERMANY: KEY MACROINDICATORS 154
TABLE 120 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 154
TABLE 121 GERMANY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 122 GERMANY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 155
TABLE 123 GERMANY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 124 GERMANY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 125 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 126 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 156
TABLE 127 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 157
TABLE 128 GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 157
11.3.2 UK 157
11.3.2.1 Supportive reimbursement policies to drive market 157
TABLE 129 UK: KEY MACROINDICATORS 158
TABLE 130 REIMBURSEMENT FOR BRONCHOSCOPY PROCEDURES IN THE UK 158
TABLE 131 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 132 UK: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 133 UK: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 159
TABLE 134 UK: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 135 UK: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 136 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 137 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 161
TABLE 138 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 161
TABLE 139 UK: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 161
11.3.3 FRANCE 161
11.3.3.1 Favorable health insurance system to drive market for bronchoscopy equipment 161
TABLE 140 FRANCE: LUNG CANCER INCIDENCE, 2020 VS. 2040 162
TABLE 141 FRANCE: KEY MACROINDICATORS 162
TABLE 142 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 143 FRANCE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 144 FRANCE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 163
TABLE 145 FRANCE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 146 FRANCE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 147 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
TABLE 148 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 164
TABLE 149 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 165
TABLE 150 FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 165
11.3.4 SPAIN 165
11.3.4.1 Well-organized and efficient healthcare system to offer growth opportunities 165
TABLE 151 SPAIN: LUNG CANCER INCIDENCE, 2018 VS. 2025 166
TABLE 152 SPAIN: KEY MACROINDICATORS 166
TABLE 153 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 166
TABLE 154 SPAIN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 155 SPAIN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 167
TABLE 156 SPAIN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 157 SPAIN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 158 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 159 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 168
TABLE 160 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 169
TABLE 161 SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 169
11.3.5 ITALY 169
11.3.5.1 Growing medical tourism and rising geriatric population key factors driving market 169
TABLE 162 ITALY: LUNG CANCER INCIDENCE, 2018 VS. 2025 170
TABLE 163 ITALY: KEY MACROINDICATORS 170
TABLE 164 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 165 ITALY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 166 ITALY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 171
TABLE 167 ITALY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 168 ITALY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 169 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 170 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 172
TABLE 171 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 173
TABLE 172 ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 173
11.3.6 REST OF EUROPE 173
TABLE 173 REST OF EUROPE: LUNG CANCER INCIDENCE, 2020 VS. 2040 174
TABLE 174 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 174
TABLE 175 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 176 REST OF EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 177 REST OF EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 175
TABLE 178 REST OF EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 REST OF EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 180 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 176
TABLE 181 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 176
TABLE 182 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 177
TABLE 183 REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 177
11.4 ASIA PACIFIC 177
TABLE 184 ASIA PACIFIC: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE FOR LUNG CANCER, BY COUNTRY, 2020 177
FIGURE 34 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT 179
TABLE 185 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 186 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 187 ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 188 ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 181
TABLE 189 ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 190 ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 191 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 192 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 182
TABLE 193 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 182
TABLE 194 ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 183
11.4.1 CHINA 183
11.4.1.1 Large patient population to favor market growth 183
TABLE 195 CHINA: KEY MACROINDICATORS 184
TABLE 196 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 184
TABLE 197 CHINA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 198 CHINA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 185
TABLE 199 CHINA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 200 CHINA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 201 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 202 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 186
TABLE 203 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 186
TABLE 204 CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 186
11.4.2 JAPAN 187
11.4.2.1 Growing geriatric population to support market growth 187
TABLE 205 JAPAN: LUNG CANCER INCIDENCE, 2020 VS. 2040 187
TABLE 206 JAPAN: KEY MACROINDICATORS 188
TABLE 207 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 188
TABLE 208 JAPAN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 209 JAPAN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 189
TABLE 210 JAPAN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 211 JAPAN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 212 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 190
TABLE 213 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 190
TABLE 214 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 190
TABLE 215 JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 190
11.4.3 INDIA 191
11.4.3.1 Healthcare infrastructural development and favorable government initiatives key factors supporting market growth 191
TABLE 216 INDIA: LUNG CANCER INCIDENCE, 2018 VS. 2025 191
TABLE 217 INDIA: KEY MACROINDICATORS 191
TABLE 218 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 192
TABLE 219 INDIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 220 INDIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 192
TABLE 221 INDIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 222 INDIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 223 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 193
TABLE 224 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 194
TABLE 225 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 194
TABLE 226 INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 194
11.4.4 AUSTRALIA 194
11.4.4.1 High prevalence of cancer to drive demand for bronchoscopy 194
TABLE 227 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 195
TABLE 228 AUSTRALIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 229 AUSTRALIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 196
TABLE 230 AUSTRALIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 231 AUSTRALIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 232 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 233 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 197
TABLE 234 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 197
TABLE 235 AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 197
11.4.5 REST OF ASIA PACIFIC 198
TABLE 236 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 198
TABLE 237 REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 238 REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 199
TABLE 239 REST OF ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 240 REST OF ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 241 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 200
TABLE 242 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 200
TABLE 243 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 201
TABLE 244 REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 201

11.5 REST OF THE WORLD 201
TABLE 245 REST OF THE WORLD: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE FOR LUNG CANCER, BY COUNTRY, 2020 201
TABLE 246 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 205
TABLE 247 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 205
TABLE 248 REST OF THE WORLD: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 249 REST OF THE WORLD: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 206
TABLE 250 ROW: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 251 ROW: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 252 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 207
TABLE 253 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 207
TABLE 254 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 207
TABLE 255 REST OF THE WORLD: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 207
11.5.1 LATIN AMERICA 208
11.5.1.1 Increasing purchasing power and healthcare affordability to favor market growth 208
TABLE 256 LUNG CANCER INCIDENCE FOR KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025 208
TABLE 257 LATIN AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 209
TABLE 258 LATIN AMERICA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 259 LATIN AMERICA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 209
TABLE 260 LATIN AMERICA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 261 LATIN AMERICA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 262 LATIN AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 210
TABLE 263 LATIN AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 211
TABLE 264 LATIN AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 211
TABLE 265 LATIN AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 211
11.5.2 MIDDLE EAST AND AFRICA 211
11.5.2.1 Healthcare infrastructural development to drive market 211
TABLE 266 AFRICA: LUNG CANCER INCIDENCE, 2018 VS. 2025 212
TABLE 267 MIDDLE EAST AND AFRICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 212
TABLE 268 MIDDLE EAST AND AFRICA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 269 MIDDLE EAST AND AFRICA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION) 213
TABLE 270 MIDDLE EAST AND AFRICA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 271 MIDDLE EAST AND AFRICA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 272 MIDDLE EAST AND AFRICA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 214
TABLE 273 MIDDLE EAST AND AFRICA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION) 214
TABLE 274 MIDDLE EAST AND AFRICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION) 214
TABLE 275 MIDDLE EAST & AFRICA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 214
12 COMPETITIVE LANDSCAPE 215
12.1 OVERVIEW 215
12.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 215
TABLE 276 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 215
12.3 REVENUE ANALYSIS 217
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN BRONCHOSCOPY EQUIPMENT MARKET 217
12.4 MARKET SHARE ANALYSIS 217
FIGURE 36 BRONCHOSCOPY EQUIPMENT MARKET SHARE ANALYSIS, 2021 218
TABLE 277 BRONCHOSCOPY EQUIPMENT MARKET: DEGREE OF COMPETITION 218
12.5 COMPANY EVALUATION MATRIX (KEY PLAYERS) 219
12.5.1 STARS 219
12.5.2 EMERGING LEADERS 220
12.5.3 PARTICIPANTS 220
12.5.4 PERVASIVE PLAYERS 220
FIGURE 37 BRONCHOSCOPY EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 220
12.6 COMPETITIVE LEADERSHIP MAPPING (STARTUPS AND SMES) 221
12.6.1 PROGRESSIVE COMPANIES 221
12.6.2 STARTING BLOCKS 221
12.6.3 RESPONSIVE COMPANIES 221
12.6.4 DYNAMIC COMPANIES 221
FIGURE 38 BRONCHOSCOPY EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/STARTUPS, 2021 222
12.7 COMPETITIVE BENCHMARKING 223
TABLE 278 BRONCHOSCOPY EQUIPMENT MARKET: DETAILED LIST OF KEY SMES/STARTUPS 223
TABLE 279 BRONCHOSCOPY EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF SMES/STARTUPS 224
12.8 COMPANY FOOTPRINT ANALYSIS 225
TABLE 280 OVERALL FOOTPRINT OF COMPANIES 225
TABLE 281 PRODUCT FOOTPRINT OF COMPANIES 226
TABLE 282 REGIONAL FOOTPRINT OF COMPANIES 227
12.9 COMPETITIVE SCENARIO AND TRENDS 228
12.9.1 PRODUCT LAUNCHES AND APPROVALS 228
TABLE 283 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019–JULY 2022 228
12.9.2 DEALS 230
TABLE 284 DEALS, JANUARY 2019–JULY 2022 230
12.9.3 OTHER DEVELOPMENTS 232
TABLE 285 OTHER DEVELOPMENTS, JANUARY 2019–JULY 2022 232
13 COMPANY PROFILES 234
13.1 KEY PLAYERS 234
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 OLYMPUS CORPORATION 234
TABLE 286 OLYMPUS CORPORATION: BUSINESS OVERVIEW 234
FIGURE 39 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 235
13.1.2 AMBU A/S 240
TABLE 287 AMBU A/S: BUSINESS OVERVIEW 240
FIGURE 40 AMBU A/S: COMPANY SNAPSHOT (2021) 241
13.1.3 BOSTON SCIENTIFIC CORPORATION 243
TABLE 288 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 243
FIGURE 41 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 244
13.1.4 ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON) 247
TABLE 289 JOHNSON & JOHNSON: BUSINESS OVERVIEW 247
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 248
13.1.5 MEDTRONIC 250
TABLE 290 MEDTRONIC: BUSINESS OVERVIEW 250
FIGURE 43 MEDTRONIC: COMPANY SNAPSHOT (2021) 251
13.1.6 FUJIFILM HOLDINGS CORPORATION 254
TABLE 291 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 254
FIGURE 44 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021) 255
13.1.7 KARL STORZ 258
TABLE 292 KARL STORZ: BUSINESS OVERVIEW 258
13.1.8 HOYA CORPORATION 260
TABLE 293 HOYA CORPORATION: BUSINESS OVERVIEW 260
FIGURE 45 HOYA CORPORATION: COMPANY SNAPSHOT (2020) 260
13.1.9 RICHARD WOLF GMBH 262
TABLE 294 RICHARD WOLF GMBH: BUSINESS OVERVIEW 262
13.1.10 COOK MEDICAL 264
TABLE 295 COOK MEDICAL: BUSINESS OVERVIEW 264
13.1.11 CONMED 266
TABLE 296 CONMED: BUSINESS OVERVIEW 266
FIGURE 46 CONMED: COMPANY SNAPSHOT (2021) 267
13.1.12 ROPER TECHNOLOGIES 269
TABLE 297 ROPER TECHNOLOGIES: BUSINESS OVERVIEW 269
FIGURE 47 ROPER TECHNOLOGIES: COMPANY SNAPSHOT (2021) 270
13.1.13 TELEFLEX INCORPORATED 272
TABLE 298 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 272
FIGURE 48 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2021) 273
13.1.14 LABORIE MEDICAL TECHNOLOGIES CORP. 275
TABLE 299 LABORIE MEDICAL TECHNOLOGIES CORP.: BUSINESS OVERVIEW 275
13.1.15 EFER ENDOSCOPY 276
TABLE 300 EFER ENDOSCOPY: BUSINESS OVERVIEW 276
13.1.16 BRONCUS MEDICAL INC. 278
TABLE 301 BRONCUS MEDICAL INC.: BUSINESS OVERVIEW 278
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 280
13.2.1 EMOS TECHNOLOGY GMBH 280
13.2.2 VBM MEDIZINTECHNIK GMBH 280
13.2.3 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD. 281
13.2.4 MACHIDA ENDOSCOPE CO., LTD. 281
14 APPENDIX 282
14.1 DISCUSSION GUIDE 282
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286
14.3 CUSTOMIZATION OPTIONS 288
14.4 RELATED REPORTS 288
14.5 AUTHOR DETAILS 289

★調査レポート[世界の気管支鏡検査市場(~2027年):製品別(気管支鏡(フレキシブル、リジッド、EBUS)、画像システム(ビデオプロセッサ)、付属品(細胞診ブラシ))、用途別(気管支治療)、有用性別(再利用可能)、エンドユーザー別(病院、ACS/クリニック)] (コード:MD7495-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の気管支鏡検査市場(~2027年):製品別(気管支鏡(フレキシブル、リジッド、EBUS)、画像システム(ビデオプロセッサ)、付属品(細胞診ブラシ))、用途別(気管支治療)、有用性別(再利用可能)、エンドユーザー別(病院、ACS/クリニック)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆